Miller Nash Graham & Dunn works with companies at all stages of development in the biotechnology sector. Our attorneys have assisted biotechnology companies in entity formation, grant funding, early stage investment, public securities offerings, securities law compliance, research and development contracts and joint ventures, inbound and outbound technology licensing, mergers and acquisitions, and other corporate transactions.
Our intellectual property team includes counsel with both business and science backgrounds relevant to growing biotechnology companies. We handle extensive patent and intellectual property portfolios for our biotechnology clients.
Like other businesses, biotechnology companies encounter issues in areas such as employment, benefits, tax, and environmental compliance. Miller Nash Graham & Dunn attorneys regularly assist and advise clients on all of these matters.